Dec 13, 2019, 12:00 PM in Universal Time UTC

Registration link:                                                                                                                                                                                     During this interactive debate organized by the International Society of Endocrinology (ISE) in partnership with the World Alliance of Pituitary Organizations (WAPO), two Key Opinion Leaders will talk about the common symptoms of Adult GHD, the lack of consensus on the preferred diagnostic model, the common controversies around starting dosages, novel pharmacological therapies, the benefits and risks of continuing therapy, and important psychological and social well-being factors faced by adult GHD patients. You will also witness a patient testimonial that will give you an insight into how it is to live with adult growth hormone deficiency and how the patient experiences the communication with their doctor. *This webinar is supported through an unrestricted educational grant from Novo Nordisk. Note: By registering for the webinar, I agree to receive information about the activities of ISE.